314 related articles for article (PubMed ID: 12436492)
1. Respiratory syncytial virus enhances respiratory allergy in mice despite the inhibitory effect of virus-induced interferon-gamma.
Barends M; Boelen A; de Rond L; Dormans J; Kwakkel J; van Oosten M; Neijens HJ; Kimman TG
J Med Virol; 2003 Jan; 69(1):156-62. PubMed ID: 12436492
[TBL] [Abstract][Full Text] [Related]
2. Timing of infection and prior immunization with respiratory syncytial virus (RSV) in RSV-enhanced allergic inflammation.
Barends M; Van Oosten M; De Rond CG; Dormans JA; Osterhaus AD; Neijens HJ; Kimman TG
J Infect Dis; 2004 May; 189(10):1866-72. PubMed ID: 15122523
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice.
Peebles RS; Sheller JR; Collins RD; Jarzecka AK; Mitchell DB; Parker RA; Graham BS
J Med Virol; 2001 Feb; 63(2):178-88. PubMed ID: 11170055
[TBL] [Abstract][Full Text] [Related]
4. [Effects of respiratory syncytial virus infection on T-helper cytokines expression in Balb/c mice sensitized with ovalbumin].
Zou Y; Xu J; Zhong N
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Aug; 25(8):470-4. PubMed ID: 12425832
[TBL] [Abstract][Full Text] [Related]
5. Respiratory syncytial virus protects against the subsequent development of Japanese cedar pollen-induced allergic responses.
Liu B; Kimura Y
J Med Virol; 2007 Oct; 79(10):1600-5. PubMed ID: 17705182
[TBL] [Abstract][Full Text] [Related]
6. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
[TBL] [Abstract][Full Text] [Related]
7. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.
Bukreyev A; Belyakov IM; Prince GA; Yim KC; Harris KK; Berzofsky JA; Collins PL
J Virol; 2005 Aug; 79(15):9515-26. PubMed ID: 16014914
[TBL] [Abstract][Full Text] [Related]
8. Influence of respiratory syncytial virus infection on cytokine and inflammatory responses in allergic mice.
Barends M; Boelen A; de Rond L; Kwakkel J; Bestebroer T; Dormans J; Neijens H; Kimman T
Clin Exp Allergy; 2002 Mar; 32(3):463-71. PubMed ID: 11940079
[TBL] [Abstract][Full Text] [Related]
9. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
10. Effects of primary and secondary low-grade respiratory syncytial virus infections in a murine model of asthma.
Kondo Y; Matsuse H; Machida I; Kawano T; Saeki S; Tomari S; Obase Y; Fukushima C; Kohno S
Clin Exp Allergy; 2004 Aug; 34(8):1307-13. PubMed ID: 15298574
[TBL] [Abstract][Full Text] [Related]
11. Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice.
Dakhama A; Lee YM; Ohnishi H; Jing X; Balhorn A; Takeda K; Gelfand EW
J Allergy Clin Immunol; 2009 Jan; 123(1):138-145.e5. PubMed ID: 19056111
[TBL] [Abstract][Full Text] [Related]
12. Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen.
Park JW; Taube C; Yang ES; Joetham A; Balhorn A; Takeda K; Miyahara N; Dakhama A; Donaldson DD; Gelfand EW
J Allergy Clin Immunol; 2003 Dec; 112(6):1078-87. PubMed ID: 14657862
[TBL] [Abstract][Full Text] [Related]
13. Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges.
Peebles RS; Hashimoto K; Collins RD; Jarzecka K; Furlong J; Mitchell DB; Sheller JR; Graham BS
J Infect Dis; 2001 Dec; 184(11):1374-9. PubMed ID: 11709778
[TBL] [Abstract][Full Text] [Related]
14. T helper lymphocyte response to respiratory syncytial virus and its components in patients with respiratory allergy and nonatopic controls.
Shimojo N; Katsuki T; Tateno N; Tomiita M; Kohno Y
Int Arch Allergy Immunol; 2008; 147(2):110-6. PubMed ID: 18520155
[TBL] [Abstract][Full Text] [Related]
15. Cytokine production from peripheral blood mononuclear cells of mite allergen-sensitized atopic adults stimulated with respiratory syncytial virus and mite allergen.
Hirose H; Matsuse H; Tsuchida T; Fukahori S; Fukushima C; Mizuta Y; Kohno S
Int Arch Allergy Immunol; 2008; 146(2):149-55. PubMed ID: 18204281
[TBL] [Abstract][Full Text] [Related]
16. An immunocompromised BALB/c mouse model for respiratory syncytial virus infection.
Kong X; Hellermann GR; Patton G; Kumar M; Behera A; Randall TS; Zhang J; Lockey RF; Mohapatra SS
Virol J; 2005 Feb; 2():3. PubMed ID: 15701174
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
[TBL] [Abstract][Full Text] [Related]
18. Effects of repeated respiratory syncytial virus infections on pulmonary dendritic cells in a murine model of allergic asthma.
Hirose H; Matsuse H; Fukahori S; Tsuchida T; Tomari S; Kawano T; Fukushima C; Mizuta Y; Kohno S
Int Arch Allergy Immunol; 2008; 147(3):197-205. PubMed ID: 18594149
[TBL] [Abstract][Full Text] [Related]
19. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus.
Graham BS; Henderson GS; Tang YW; Lu X; Neuzil KM; Colley DG
J Immunol; 1993 Aug; 151(4):2032-40. PubMed ID: 8345194
[TBL] [Abstract][Full Text] [Related]
20. Suppression of IFN-gamma production in atopic group at the acute phase of RSV infection.
Kaneko H; Matsui E; Asano T; Kato Z; Teramoto T; Aoki M; Kawamoto N; Lian LA; Kasahara K; Kondo N
Pediatr Allergy Immunol; 2006 Aug; 17(5):370-5. PubMed ID: 16846456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
